Inventor
RAJINDER SINGH
Inventor
US
Overview
Patents· 73 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
A61KPreparations for medical, dental or toiletry purposes21%
C07DHeterocyclic compounds20%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
Y02ATechnologies for adaptation to climate change4%
C07CAcyclic or carbocyclic compounds3%
C07KPeptides3%
C07BGeneral methods of organic chemistry2%
G08BSignalling systems, e.g. personal calling systems2%
H04WWireless communication networks2%
PatentTitleYear
12,556,763Dynamic masking for media playback202612,533,354Triaryl compounds for treatment of PD-L1 diseases202612,513,127End to end encryption of data in an electronic monitoring system202512,417,362Dynamic image based contactless instructions for an electronic monitoring system202512,368,597Method and system for the secure onboarding of low energy peripheral devices202512,275,732Cyclic compounds as receptor modulating therapeutics and methods and uses thereof202512,227,508TGF-b inhibitors202512,194,032Method of treating focal segmental glomerulosclerosis202512,184,741Method to securely update over-the-air firmware202412,148,277Electronic monitoring system using push notifications with custom audio alerts202412,139,473Substituted-N-heteroaryl compounds and uses thereof202412,139,4752-oxindole compounds202412,092,600Resistivity imaging system with compensator for parasitic impedances between electrodes and their conductive substrates202412,090,146Substituted-pyridinyl compounds and uses thereof202412,058,968Mads-box domain alleles for controlling shell phenotype in palm202412,043,620Benzazole compounds and methods for making and using the compounds202412,011,439Combination therapy using C--C chemokine receptor 4 (CCR4) antagonists and one or more immune checkpoint inhibitors202411,993,594IRAK inhibitors and method for making and using202411,986,466Methods of treating solid tumors with CCR2 antagonists202411,939,317Amide compounds and method for making and using202411,941,320Electronic monitoring system having modified audio output202411,883,391Compositions and methods for treating inflammatory bowel disease using CCR9 inhibitor and anti-IL-23 blocking antibodies202411,884,673Modulators of ion channel receptors and uses thereof202411,872,217Indanes as PD-L1 inhibitors202411,844,790Methods of treating hidradenitis suppurativa202311,827,628Compositions and methods for inhibition of the JAK pathway202311,820,759Modulators of chemokine receptors202311,807,609Deuterated compounds as immunomodulators202311,793,771Immunomodulator compounds202311,773,0916-5 fused rings as C5a inhibitors202311,759,458Indane-amines as PD-L1 antagonists202311,708,326Immunomodulator compounds202311,691,985Macrocyclic immunomodulators202311,684,606Methods of treating generalized pustular psoriasis with an antagonist of CCR6 or CXCR2202311,672,791Tyrosine kinase inhibitors202311,667,611Compositions and methods for inhibition of the JAK pathway202311,654,759Sealing apparatus for a laterally-sliding door202311,632,922Mantle phenotype detection in palm202311,608,336Prodrugs of fused-bicyclic C5aR antagonists202311,603,356Amorphous form of a complement component C5a receptor202311,560,601Gene controlling fruit color phenotype in palm202311,530,194Amide compounds and method for making and using202211,524,9552,4-diamino-pyrimidine compounds and method for making and using the compounds202211,492,349IRAK inhibitors and method for making and using202211,485,737Diaryl substituted 5,5-fused ring compounds as C5aR inhibitors202211,485,708Compounds for treatment of PD-L1 diseases202211,466,018TGF-b inhibitors202211,446,289Combination therapy using C-C chemokine receptor 4 (CCR4) antagonists and one or more immune checkpoint inhibitors202211,434,2302-oxindole compounds202211,427,541Salt forms of a complement component C5A receptor202211,426,364Immunomodulator compounds202211,382,915Treatment of focal segmental glomerulosclerosis with CCR2 antagonists202211,384,0796-5 fused rings as C5a inhibitors202211,384,085Modulators of ion channel receptors and uses thereof202211,371,104Gene controlling shell phenotype in palm202211,370,808Pyrazole compounds and methods for making and using the compounds202211,352,360TGF-beta inhibitors202211,324,736Method of Treating Focal Segmental Glomerulosclerosis202211,304,952Combination therapy using a chemokine receptor 2 (CCR2) antagonist and a PD-1/PD-L1 inhibitor202211,299,486Benzazole compounds and methods for making and using the compounds202211,279,686Nrf2 activating compounds and uses thereof202211,266,643Triaryl compounds for treatment of PD-L1 diseases202211,230,554Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds2022RE048898Prodrugs of 2,4-pyrimidinediamine compounds and their uses202211,220,496Compounds and method for treating autoimmune diseases202211,207,294Methods of treating generalized pustular psoriasis with an antagonist of CCR6 or CXCR2202111,198,689Compositions and methods for inhibition of the JAK pathway202111,174,251Compositions and methods for inhibition of the JAK pathway202111,174,246Direct AMPK activators202111,159,772Electronic doorbell system with camera selection202111,154,556Methods of treating solid tumors with CCR2 antagonists202111,145,171Electronic doorbell system with text communication202111,135,210Indane-amines as PD-L1 antagonists2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2026Patents assigned to CHEMOCENTRYX INC (32)· patent assignee history
2021–2025Patents assigned to RIGEL PHARMACEUTICALS INC (21)· patent assignee history
2021–2026Patents assigned to ARLO TECH INC (9)· patent assignee history
2021–2026Based in US· patent location history
2022–2025Patents assigned to BIONOMICS LTD (5)· patent assignee history
2022–2024Patents assigned to MALAYSIAN PALM OIL BOARD (4)· patent assignee history
2022–2025Based in AU· patent location history
2022–2024Based in MY· patent location history
2024Based in GB· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CHEMOCENTRYX INC | 32 | 2021–2026 |
| RIGEL PHARMACEUTICALS INC | 21 | 2021–2025 |
| ARLO TECH INC | 9 | 2021–2026 |
| BIONOMICS LTD | 5 | 2022–2025 |
| MALAYSIAN PALM OIL BOARD | 4 | 2022–2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 63 | 2021–2026 |
| AU | 5 | 2022–2025 |
| MY | 4 | 2022–2024 |
| GB | 1 | 2024 |